Streetbeat News

Partnerships

GSK

Elsie Biotechnologies has announced a research collaboration with GSK plc (NYSE:GSK) to advance the discovery and development of Elsie’s oligonucleotide discovery platform. The collaboration will combine GSK's expertise in DNA encoded library technologies with Elsie's drug discovery platform. GSK may exercise an option to a non-exclusive license from Elsie for the discovery platform and P(V) chemistry technologies.

Portfolio Pulse from Charles Gross

July 10, 2023 | 11:05 am

BDTX

NBTX

NSTG

Several stocks recorded gains in today's pre-market trading session. Nanobiotix S.A. shares jumped 59.3% after entering into a license agreement with Janssen Pharmaceutical. Black Diamond Therapeutics shares gained 15.2% following a large purchase by Director Rajeev Shah. NanoString Technologies shares gained 13.4% after announcing expected Q2 sales of over $44 million. Other stocks recording gains include Novonix Limited, Ferroglobe PLC, Gorilla Technology Group Inc., Recursion Pharmaceuticals, Inc., CS Disco, Inc., and Polestar Automotive Holding UK PLC.

Portfolio Pulse from Lisa Levin

July 10, 2023 | 10:40 am

MTTR

Matterport, Inc. (NASDAQ:MTTR) has announced a partnership with Equinox Technologies to distribute its digital twin platform to Government, Enterprise and SMB customers in the Middle East and Africa. The partnership is part of the region's trillion-dollar urbanization efforts.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 10:02 am

NDAQ

Nasdaq Inc has partnered with B3 to create a new clearing platform for the Brazilian stock exchange. The platform will facilitate the clearing, settlement, and management of counterparty risk related to financial market trades. Nasdaq will use its expertise to offer real-time clearing solutions to over 20 central counterparty clearing houses globally. In exchange, the Brazilian stock exchange will aid advancements in Nasdaq's clearing platform.

Portfolio Pulse from Lekha Gupta

July 10, 2023 | 9:43 am

LLY

Remegen has announced a clinical research and supply agreement with Innovent Biologics to explore combination therapies of antibody-drug conjugates with Tyvyt (Sintilimab). Tyvyt is developed collaboratively by Innovent and Eli Lilly.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 9:09 am

NBTX

Nanobiotix has entered into a global co-development and commercialization license agreement with Janssen Pharmaceutical for NBTXR3, leading to a rise in Nanobiotix's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 8:21 am

NDAQ

B3 and Nasdaq (NASDAQ:NDAQ) have announced a partnership to develop a new clearing platform for the Brazilian stock exchange. The multi-year collaboration will involve close work between engineering teams, leveraging Nasdaq's expertise in real-time clearing solutions and B3's experience in operating high-volume markets.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 8:02 am

JNJ

NBTX

Nanobiotix has entered into a license agreement with Janssen Pharmaceutical for the worldwide co-development and commercialization of potential first-in-class radioenhancer NBTXR3.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 6:19 am

UNP

Union Pacific (UNP) has reached a tentative agreement with the SMART-TD labor union on paid sick leave. The details of the agreement have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 4:08 am

FXI

SPY

U.S. Treasury Secretary has visited China with the aim to establish and deepen ties with China's new economic team and reduce misunderstanding risks. The meetings have been described as direct, substantive, and productive, putting U.S.-China ties on a surer footing.

Portfolio Pulse from Charles Gross

July 09, 2023 | 1:13 am